CCND2 and esophageal cancer: We found that CCND2 was significantly promoter hypermethylated and lower when expressed in lung adenocarcinoma and TNBC as compared with adjacent normal tissues and other cancers, such as colon cancer, liver cancer, gastric cancer, and esophageal cancer.